The Epidemiology Group within the Institute of Applied Health Science has the following aims with respect to arthritis and musculoskeletal health:
- To understand their epidemiology, with a focus on modifiable risk factors
- To conduct trials of management with the goal of preventing onset or improving outcome
- To design, implement and evaluate health services for patients with these conditions
Our clinical focus is on common disabling conditions (musculoskeletal pain, including fibromyalgia, and fatigue), inflammatory disorders (axial spondyloarthritis and psoriatic arthritis) as well as rare conditions (vasculitis)
We also undertake methodological work within each of these three areas of research and conduct our work using a variety of approaches including both quantitative and qualitative approaches.
Professor Gary J Macfarlane, head of the Epidemiology Group, is Chair (Clinical) of Epidemiology, Deputy Director of the Institute of Applied Health Sciences and is an Honorary Consultant in the Department of Public Health at NHS Grampian.
Our work on Rheumatic and Musculoskeletal Disorders:
- was awarded European League Against Rheumatism (EULAR) "Centre of Excellence in Rheumatology" status for the period 2010-15, which has been renewed for the period of 2015-2020
- is part-funded within the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Work